Jupiter Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.3M | Buy |
2,627,160
+183,515
| +8% | +$4.8M | 0.31% | 89 |
|
|
2026
Q1 | $68.6M | Hold |
2,443,645
| – | – | 0.37% | 85 |
|
|
2025
Q4 | $60.8M | Sell |
2,443,645
-2,102
| -0.1% | -$53K | 0.49% | 58 |
|
|
2025
Q3 | $62.3M | Buy |
2,445,747
+719,768
| +42% | +$17.8M | 0.54% | 55 |
|
|
2025
Q2 | $41.8M | Buy |
1,725,979
+156,952
| +10% | +$3.66M | 0.35% | 102 |
|
|
2025
Q1 | $39.8M | Buy |
1,569,027
+822,518
| +110% | +$21.5M | 0.38% | 90 |
|
|
2024
Q4 | $19.8M | Buy |
746,509
+638,259
| +590% | +$17.3M | 0.19% | 164 |
|
|
2024
Q3 | $3.13M | Sell |
108,250
-1,185
| -1% | -$34.6K | 0.03% | 300 |
|
|
2024
Q2 | $3.06M | Sell |
109,435
-6,654
| -6% | -$183K | 0.03% | 296 |
|
|
2024
Q1 | $3.22M | Buy |
+116,089
| New | +$3.22M | 0.03% | 282 |
|
|
2023
Q3 | – | Sell |
-174,317
| Closed | -$6.39M | – | 563 |
|
|
2023
Q2 | $6.39M | Sell |
174,317
-352,042
| -67% | -$13.7M | 0.07% | 261 |
|
|
2023
Q1 | $21.5M | Buy |
526,359
+498,804
| +1,810% | +$21.5M | 0.3% | 107 |
|
|
2022
Q4 | $1.41M | Sell |
27,555
-467,213
| -94% | -$22.4M | 0.02% | 348 |
|
|
2022
Q3 | $21.7M | Buy |
494,768
+364,002
| +278% | +$17.7M | 0.33% | 82 |
|
|
2022
Q2 | $6.87M | Sell |
130,766
-387,356
| -75% | -$19.7M | 0.1% | 216 |
|
|
2022
Q1 | $26.8M | Buy |
+518,122
| New | +$26.9M | 0.32% | 97 |
|
|
2021
Q1 | – | Sell |
-7,612
| Closed | -$280K | – | 640 |
|
|
2020
Q4 | $280K | Sell |
7,612
-1,124,855
| -99% | -$41.3M | ﹤0.01% | 553 |
|
|
2020
Q3 | $39.4M | Buy |
+1,132,467
| New | +$39.7M | 0.42% | 55 |
|
|
2020
Q2 | – | Sell |
-287,098
| Closed | -$8.89M | – | 272 |
|
|
2020
Q1 | $8.89M | Sell |
287,098
-22,897
| -7% | -$780K | 0.38% | 76 |
|
|
2019
Q4 | $11.5M | Sell |
309,995
-47,567
| -13% | -$1.69M | 0.36% | 80 |
|
|
2019
Q3 | $12.2M | Sell |
357,562
-74,025
| -17% | -$2.69M | 0.4% | 65 |
|
|
2019
Q2 | $17.7M | Hold |
431,587
| – | – | 0.56% | 48 |
|
|
2019
Q1 | $17.4M | Sell |
431,587
-130,197
| -23% | -$5.21M | 0.56% | 48 |
|
|
2018
Q4 | $23.3M | Sell |
561,784
-121,290
| -18% | -$5.04M | 0.82% | 28 |
|
|
2018
Q3 | $28.5M | Sell |
683,074
-27,723
| -4% | -$1.07M | 0.81% | 28 |
|
|
2018
Q2 | $24.5M | Sell |
710,797
-15,800
| -2% | -$540K | 0.72% | 33 |
|
|
2018
Q1 | $24.5M | Sell |
726,597
-100,520
| -12% | -$3.46M | 0.74% | 28 |
|
|
2017
Q4 | $28.4M | Buy |
827,117
+23,904
| +3% | +$815K | 0.82% | 27 |
|
|
2017
Q3 | $27.2M | Buy |
803,213
+22,085
| +3% | +$710K | 0.93% | 26 |
|
|
2017
Q2 | $24.9M | Buy |
781,128
+37,914
| +5% | +$1.2M | 0.86% | 23 |
|
|
2017
Q1 | $24.1M | Hold |
743,214
| – | – | 0.88% | 25 |
|
|
2016
Q4 | $22.9M | Sell |
743,214
-54,909
| -7% | -$1.68M | 0.86% | 26 |
|
|
2016
Q3 | $25.6M | Sell |
798,123
-158,325
| -17% | -$5.29M | 0.97% | 20 |
|
|
2016
Q2 | $32M | Sell |
956,448
-43,932
| -4% | -$1.4M | 1.22% | 13 |
|
|
2016
Q1 | $28.1M | Buy |
1,000,380
+2,544
| +0.3% | +$72.7K | 1.07% | 21 |
|
|
2015
Q4 | $30.6M | Sell |
997,836
-60,851
| -6% | -$1.91M | 1.12% | 20 |
|
|
2015
Q3 | $31.6M | Buy |
1,058,687
+21,884
| +2% | +$702K | 1.23% | 19 |
|
|
2015
Q2 | $33M | Sell |
1,036,803
-59,253
| -5% | -$1.93M | 1.16% | 20 |
|
|
2015
Q1 | $36.2M | Buy |
1,096,056
+62,905
| +6% | +$2M | 1.26% | 17 |
|
|
2014
Q4 | $30.5M | Sell |
1,033,151
-14,598
| -1% | -$419K | 0.99% | 21 |
|
|
2014
Q3 | $29.4M | Sell |
1,047,749
-28,835
| -3% | -$809K | 0.98% | 21 |
|
|
2014
Q2 | $30.3M | Sell |
1,076,584
-5,059
| -0.5% | -$144K | 0.96% | 19 |
|
|
2014
Q1 | $33M | Sell |
1,081,643
-1,921
| -0.2% | -$57.3K | 1.06% | 16 |
|
|
2013
Q4 | $31.5M | Sell |
1,083,564
-60,870
| -5% | -$1.77M | 1.22% | 16 |
|
|
2013
Q3 | $31.2M | Buy |
1,144,434
+20,883
| +2% | +$568K | 1.37% | 13 |
|
|
2013
Q2 | $29.9M | Buy |
+1,123,551
| New | +$31M | 1.33% | 12 |
|
Other funds holding PFE
Jupiter Asset Management's PFE Position: Q2 2026 in Review
Jupiter Asset Management increased its Pfizer (PFE) stake by 7.5% in Q2 2026, buying an estimated $4.8M and bringing the position to 2,627,160 shares worth $63.3M. The position accounts for 0.31% of the portfolio, ranked #89.
Jupiter Asset Management first reported a position in PFE in Q2 2013 and has held it in 46 quarters since. The position peaked at $68.6M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Jupiter Asset Management held 2,627,160 shares of Pfizer worth $63.3M as of Q2 2026.
- Jupiter Asset Management bought 183,515 Pfizer shares in Q2 2026, an estimated $4.8M.
- Pfizer made up 0.31% of Jupiter Asset Management's portfolio in Q2 2026, its #89 holding.
- Jupiter Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 46 quarters since.
- Jupiter Asset Management's Pfizer position peaked at $68.6M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.